- Home
- CMPX vs EDD Comparison
CMPX vs EDD Comparison
Compare CMPX & EDD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMPX
- EDD
- Stock Information
- Founded
- CMPX 2014
- EDD 2007
- Country
- CMPX United States
- EDD United States
- Employees
- CMPX N/A
- EDD N/A
- Industry
- CMPX Biotechnology: Pharmaceutical Preparations
- EDD Finance Companies
- Sector
- CMPX Health Care
- EDD Finance
- Exchange
- CMPX Nasdaq
- EDD Nasdaq
- Market Cap
- CMPX 291.8M
- EDD 329.4M
- IPO Year
- CMPX N/A
- EDD N/A
- Fundamental
- Price
- CMPX $3.44
- EDD $5.37
- Analyst Decision
- CMPX Strong Buy
- EDD
- Analyst Count
- CMPX 8
- EDD 0
- Target Price
- CMPX $13.50
- EDD N/A
- AVG Volume (30 Days)
- CMPX 1.4M
- EDD 254.3K
- Earning Date
- CMPX 08-11-2025
- EDD 01-01-0001
- Dividend Yield
- CMPX N/A
- EDD 7.52%
- EPS Growth
- CMPX N/A
- EDD N/A
- EPS
- CMPX N/A
- EDD N/A
- Revenue
- CMPX N/A
- EDD N/A
- Revenue This Year
- CMPX N/A
- EDD N/A
- Revenue Next Year
- CMPX N/A
- EDD N/A
- P/E Ratio
- CMPX N/A
- EDD N/A
- Revenue Growth
- CMPX N/A
- EDD N/A
- 52 Week Low
- CMPX $1.27
- EDD $4.22
- 52 Week High
- CMPX $4.08
- EDD $4.95
- Technical
- Relative Strength Index (RSI)
- CMPX 62.85
- EDD 60.31
- Support Level
- CMPX $3.29
- EDD $5.21
- Resistance Level
- CMPX $3.52
- EDD $5.32
- Average True Range (ATR)
- CMPX 0.18
- EDD 0.06
- MACD
- CMPX 0.04
- EDD -0.00
- Stochastic Oscillator
- CMPX 81.68
- EDD 72.73
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.
About EDD Morgan Stanley Emerging Markets Domestic Debt Fund Inc.
Morgan Stanley Emerging Markets Domestic Debt Fund Inc is a closed-end management investment company. The company's primary investment objective is to seek a high level of current income, with a secondary investment objective of long-term capital appreciation. It seeks to achieve investment objectives by investing, under normal circumstances, at least 80% of its managed assets in emerging markets domestic debt. The fund's portfolio includes sovereign, quasi-sovereign, corporate bonds in emerging markets.